Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.

Tran, Giao

Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia. [electronic resource] - Asia-Pacific journal of clinical oncology Sep 2013 - 239-48 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1743-7563

10.1111/ajco.12044 doi


Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Australia
Capecitabine
Colorectal Neoplasms--drug therapy
Cost-Benefit Analysis
Deoxycytidine--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Leucovorin--administration & dosage
Male
Neoplasm Metastasis
Organoplatinum Compounds--administration & dosage
Oxaloacetates
Randomized Controlled Trials as Topic--economics